Quantifying the tradeoffs of active surveillance for low-risk prostate cancer: A clinical decision analysis.
D. Liu
No relevant relationships to disclose
H. P. Lehmann
No relevant relationships to disclose
K. D. Frick
No relevant relationships to disclose
B. Carter
No relevant relationships to disclose